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Background: The Northwestern University Center for Education and Research on Therapeutics (CERT), funded by
the Agency for Healthcare Research and Quality, is one of seven such centers in the USA. The thematic focus of the
Northwestern CERT is ‘Tools for Optimizing Medication Safety.’ Ensuring drug safety is essential, as many adults
struggle to take medications, with estimates indicating that only half of adults take drugs as prescribed. This report
describes the methods and rationale for one innovative project within the CERT: the ‘Primary Care, Electronic Health
Record-Based Strategy to Promote Safe and Appropriate Drug Use’.
Methods/Design: The overall objective of this 5-year study is to evaluate a health literacy-informed, electronic health
record-based strategy for promoting safe and effective prescription medication use in a primary care setting. A total of
600 English and Spanish-speaking patients with diabetes will be consecutively recruited to participate in the study.
Patients will be randomized to receive either usual care or the intervention; those in the intervention arm will receive a
set of print materials designed to support medication use and prompt provider counseling and medication reconciliation.
Participants will be interviewed in person after their index clinic visit and again one month later. Process outcomes related
to intervention delivery will be recorded. A medical chart review will be performed at 6 months. Patient outcome
measures include medication understanding, adherence and clinical measures (hemoglobin A1c, blood pressure,
and cholesterol; exploratory outcomes only).
Discussion: Through this study, we will be able to examine the impact of a health literacy-informed, electronic
health record-based strategy on medication understanding and adherence among diabetic primary care patients.
The measurement of process outcomes will help inform how the strategy might ultimately be refined and disseminated
to other sites. Strategies such as these are needed to address the multifaceted challenges related to medication
self-management among patients with chronic conditions.
Trial registration: Clinicaltrials.gov NCT01669473.
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According to the Institute of Medicine, more than 1.5
million preventable drug events occur each year in the
USA [1]. A third of these occur in outpatient settings, at
a cost of approximately $4.2 billion annually [1]. Ensuring
safe medication use is likely to become increasingly im-
portant as the number of adults taking prescription medi-
cations has risen dramatically [2]. Nearly half of Americans
take at least one prescription medication, and one in ten
takes five or more drugs, an increase of 70% since 1999 [2].
Despite frequent use, many adults struggle to take medi-
cations, with estimates indicating that only half of adults
take drugs as prescribed [3]. Medication use may be par-
ticularly challenging for diabetic patients, who must often
manage multiple comorbidities and complex multidrug
regimens. Patients with low health literacy and limited
English proficiency are likely to experience even greater
confusion and negative medication-related outcomes,
emphasizing the need for innovative and effective strat-
egies to promote positive medication-related outcomes
in this vulnerable population [4-6].
To address these challenges, we designed a health
literacy-informed, electronic health record based strategy
for promoting safe and effective prescription medication
use among English and Spanish-speaking patients with
diabetes mellitus. This project is one of four thematically
related projects within the Northwestern University
Center for Education and Research on Therapeutics
(CERT). Funded by the Agency for Healthcare Research
and Quality, the ‘Tools for Optimizing Medication Safety’
CERT is one of seven such centers created to promote op-
timal use of medications and to raise patient awareness of
drug risks and benefits. In this paper, we provide an over-
view of our intervention, summarize evaluation activities,
and discuss the sustainability and potential dissemination
of our novel strategy.
Methods/Design
This study seeks to reduce the patient confusion that
often leads to unintentional medication non-adherence
or medication errors. To promote sustainability and dis-
semination, we are utilizing an electronic health record
platform to automate the delivery of patient-centered medi-
cation information materials. The specific aims of the study
are as follows: (1) to refine and field test an electronic
health record strategy for generating and distributing
low-literacy prescription information for English- and
Spanish-speaking primary care patients with diabetes;
(2) to assess the process of the electronic health record
intervention and its fidelity for providing understand-
able and actionable prescription information for patients
at the point of prescribing; and (3) to evaluate the effect-
iveness of the electronic health record-based strategy
to improve medication understanding, reconciliation,regimen consolidation, and adherence, compared with
standard care. We have an additional exploratory aim
to examine the effect of the intervention on surrogate
clinical outcomes; hemoglobin A1c, low-density lipo-
protein cholesterol and blood pressure.
This study is being conducted at the University of Illinois
Hospital and Health Sciences System, an urban, academic
medical center located in Chicago, which uses Cerner
Powerchart®, a common electronic health record sys-
tem. Patients are enrolled from three primary care sites:
a resident-staffed general medicine clinic, a medicine/
pediatrics clinic, and a faculty primary care clinic. These
clinics serve a diverse, low-income patient population that
is approximately 65% African American and 20% Hispanic.
An estimated 36% of general medicine clinic patients have
limited health literacy. Adjusted for patient volume, ap-
proximately 25% of these low literacy patients have been
diagnosed with diabetes. The current standard of care in
this clinic is for patients to receive a basic after-visit
summary that describes the medical visit and includes a
list of medications prescribed to the patient according
to the electronic health record. This summary has not
been designed according to health literacy best practices
and patient education materials are not routinely given as
part of standard care.
We will recruit 600 patients from participating clinics
in no set proportion and randomize each to receive either
standard care or the intervention. Participants will be eli-
gible if they: (1) are over 18 years old; (2) have a docu-
mented diagnosis of diabetes; (3) are currently taking at
least three daily, chronic, non-PRN (not pro re nata) medi-
cations; (4) speak English or Spanish; (5) have no intention
to change clinics within the next year; (6) score 4 or higher
on a six-item cognitive screener [7]; (7) are, by self-report,
primarily responsible for taking their own medications;
and (8) were prescribed a new medication, or have a dose,
refill, or frequency change of a current medication for
hypertension, hyperlipidemia, or diabetes mellitus during
their index clinic visit.
Potentially eligible patients (criteria 1 to 4 above) are
first identified via a review of their electronic health re-
cords. A list of those patients with a clinic appointment
scheduled within the next three months is then compiled
and sent to clinic physicians via secure email. Physicians
have the opportunity to indicate which potentially eligible
patients should not be contacted, owing to severe illness or
cognitive concerns. With physician approval, patients will
be approached by the research assistant to confirm eligibil-
ity following their doctor’s appointment. Research assistants
will speak with potential participants after receiving an
electronic message that they have been prescribed a new
medication or received a changed dose or frequency of a
medication of interest. Eligibility criteria will be confirmed
before patients provide written consent and are enrolled
Przytula et al. Trials  (2015) 16:17 Page 3 of 6into the study. The study has been approved by institu-
tional review boards at the University of Illinois in Chicago
(2012–0262) and Northwestern (STU00064056) and is also
registered on clinicaltrials.gov (NCT01669473).
Patients in the intervention arm will receive three elec-
tronic health record-generated items at their clinic visit:
(1) a pre-visit medication list, (2) medication information
sheets, and (3) a post-visit medication list. These mate-
rials were designed by study team members and incorp-
orate health literacy best practices, with Lexile analyses
confirming a readability level of <8th grade [8,9]. The
medication sheets and pre-visit medication list were pre-
viously tested in a National Institutes of Health study
(R18HS17220). All materials were translated into Span-
ish using a committee-based approach and pilot tested
among English- and Spanish-speaking patients (N = 9) to
ensure comprehensibility [10]. The materials are as follows:
1. The pre-visit medication list is generated on check-in
and includes all medications prescribed to the patient
according to their electronic health record. It lists the
dosage, frequency and indication for all medications.
The instructions on the form ask patients to report
how much of each medication they take on a daily
basis and if they have any concerns (need refill, cost,
and so on) for any of the drugs. Patients are then
asked to add any additional prescription or over-the-
counter medications they are using and to remove
medications that they are no longer taking. Forms are
designed to be shared with providers during the clinic
visit to promote medication reconciliation.
2. If the patient is prescribed a new or dose-adjusted
medication for diabetes, hyperlipidemia, or
hypertension, a medication information sheet for
that medicine will print automatically in the patients’
preferred language (English or Spanish). The
medication information sheet is a one-page,
plain-language information sheet that describes
the medication’s indication for use, general directions,
and side effects. It is designed to be patient-friendly
and to provide essential need-to-know information for
each drug.
3. Following the visit, patients receive an updated post-
visit medication list, which reflects any changes
made to the pre-visit medication list as a result of
their visit that day. The post-visit medication list
includes all of the patient’s medications, listing
dosage, indication, and the times each medication
should be taken. It is intended to help patients
organize their regimen according to the Universal
Medication Schedule [11]. The Universal Medication
Schedule ‘grounds’ medication use by providing
more explicit times to describe when medicine
should be taken (morning, noon, evening, bedtime)[5]. This concept was reviewed and recommended
by the Institute of Medicine, the US Pharmacopeia,
and the National Council for Prescription Drug
Programs as a health literacy best practice. Patients
in the intervention arm will receive this post-visit
medication list, while those in usual care will receive a
standard ‘after-visit summary’ recently implemented at
the University of Illinois Hospital and Health Sciences
System to comply with meaningful use requirements
[12]. This standard after-visit summary is the only
educational print material that patients in the usual
care arm routinely receive after their clinic visit.
We will interview each patient in person at baseline,
immediately following the index clinic visit, and one
month after the index visit. At 6 months, a chart ab-
straction will be conducted to extract clinical surrogate
outcome data (hemoglobin A1c, blood pressure, and
low-density lipoprotein cholesterol).
Process outcomes
As part of the intervention delivery, we will explore process
outcome measures, such as the proportion of patients who
automatically received the pre-visit medication list, the
proportion of patients who used the intervention materials
at home, and whether the intervention materials prompted
physician-patient discussion.
Study outcomes
This study is designed to target four key medication-
related outcomes: medication reconciliation, medication
understanding, regimen consolidation, and medication
adherence.
Medication reconciliation
Numerous studies have shown discrepancies between the
medications that patients report taking and those listed in
their medical chart, undermining the quality and safety of
clinical care [13-16]. The pre-visit medication list is de-
signed to prompt greater physician-patient communica-
tion about medication use and to ensure that self-reported
medication use matches the medications listed in the pa-
tient’s chart. To measure medication reconciliation, we
will ask patients, during the one-month follow-up inter-
view, what medications they are taking. We will compare
self-reports with the medications listed in their chart.
Research assistants will note any discrepancies and ask
patients whether they are taking any medications that
were not named but are listed in their charts. Similarly,
the research assistant will inquire after any medications
that the patient reports taking but are not on their
medication list. This outcome will then be coded as: (1)
no discrepancies present between self-report and med-
ical chart or (2) discrepancies present. The number of
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warded to supervising physicians in the research team
for review, with clinically significant discrepancies being
communicated to the patient’s primary care doctor imme-
diately. This coding schema is consistent with previous
studies on medication reconciliation [14,15].
Medication understanding
Numerous studies have found limited literacy skills and
limited English proficiency to be associated with poorer
recall of medication names and indications, inadequate
understanding of prescription instructions and precau-
tions, and poorly demonstrated use of medications and
devices [11,17]. To measure patients’ understanding of
their medication regimens, research assistants will guide
each patient through a pill-dosing demonstration. Spe-
cifically, patients will be given a tray with 24 compart-
ments, each representing one hour of the day. Patients
will be oriented to the tray and then asked to show how
they take each of their medications over a 24 hour period
of time, using the tray and colored beads that represent
pills. Research assistants will record when patients indicate
that they take their medications, including dose, fre-
quency, and spacing between doses; this will be coded
as correct or incorrect, based on pre-established coding
criteria [18].
Regimen consolidation
As part of this dosing exercise, we will also measure
patients’ consolidation of their medication regimen.
Research indicates an inverse relationship between
dosing frequency and adherence [19-21]. Despite this,
a recent study by our team demonstrated that many
patients unnecessarily overcomplicate medication use
by not consolidating a complex regimen so that it can
be taken the minimum number of times per day [5].
Using the data from the dosing exercise, we will measure
regimen consolidation, defined as the number of times per
day when medication is taken, as indicated in the dosing
exercise.
Medication adherence
Non-adherence to prescribed medications is well docu-
mented, highly prevalent, and common among patients
with chronic conditions, with nearly half of patients taking
less than 80% of their prescribed doses [3,22-24]. For this
study, where data on adherence to multiple medications is
collected, using technology such as medication event mon-
itoring systems is not feasible. We are therefore following
other adherence measurement guidelines and triangulating
multiple measures of adherence [25]. Medication adher-
ence will be assessed using the Morisky general measure of
adherence, a directly observed pill count, and a 4-day self-
reported assessment of pills missed [26].Key covariates
We will collect data on a number of key covariates,
including age, sex, English proficiency, comorbidities,
medication and healthcare utilization, income, and race
and ethnicity. Health literacy will be measured using the
Newest Vital Sign [27].
Analyses
A sample size of 600 patients, 300 in each arm, was de-
termined for this research study based on sample size
calculations for the outcome measure of medication un-
derstanding. Assuming an overall baseline rate of under-
standing of 65%, a sample of 300 patients per arm would
enable the detection of an 11% absolute increase in
medication understanding with 80% power. These differ-
ences were considered appropriate, based on the results
of prior studies conducted by this study team [17,28,29].
This sample size also supports our exploratory analyses
for the effects of the intervention on surrogate clinical
outcomes. For example, a sample size of 600 provides
adequate power (86%) to detect a difference of 3 mm Hg
in mean systolic blood pressure by study arm, assuming
a standard deviation of 12.
We will perform intent-to-treat analyses to determine
the study results. Before conducting formal analyses, we
will perform descriptive statistics to ensure adequate bal-
ance of patient characteristics across the two treatment
arms (usual care and intervention) at baseline; t tests
and χ2 tests will be used to evaluate differences across
the two arms for continuous and binary variables, respect-
ively. Generalized linear models will be used for data
analyses using PROC GENMOD in SAS (version 9.2),
specifying the logit link function for binary outcomes
(medication understanding, reconciliation, adherence,
and regimen consolidation) and the identity link function
for continuous outcomes (blood pressure, hemoglobin
A1c). The treatment group will be the independent vari-
able of primary interest and will be modeled with usual
care specified as the reference group. Any potential con-
founding covariates noted in the descriptive analysis will
also be included in the models.
Discussion
Innovative low-cost interventions are necessary to
standardize and improve the currently fragmented system
of patient medication information. If found effective, our
strategy could serve as a model for providing language-
appropriate, easy-to-understand medication information
and support to patients to improve medication self-
management in ambulatory care settings. With a focus
on low health literacy, limited English proficiency, and
multiple chronic conditions, our strategy seeks to pro-
mote safe and appropriate medication use among those
at the greatest risk of poor medication-related outcomes.
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and patient misunderstanding by improving access to
high-quality medication information and by prompting
improved patient-provider communication. The strategy
also involves producing an enhanced patient-centered
medication summary in compliance with Joint Commis-
sion and Meaningful Use mandates [30,31]. Although the
process of initially integrating the materials into the elec-
tronic health record is technical and time-intensive, once
programming is completed, the intervention is low-cost,
automated, and would require limited occasional adjust-
ments compared with alternative approaches, particularly
those involving additional staff support. As the majority of
community health clinics now have an electronic health
record, this strategy is increasingly feasible and can be dis-
seminated to health centers across the nation [32].
The challenge of medication therapy management goes
beyond effective risk communication by also seeking be-
havioral maintenance in support of sustained adherence to
prescribed regimens. We hope to learn what our strategy
can contribute to appropriate, safe medication use, how it
might ultimately be disseminated, and also how it might
be supplemented to address the multifaceted problem of
medication self-management [33].
Trial status
The study is currently enrolling participants. Enrollment
began on 16 June 2013 and is anticipated to conclude in
the summer of 2016.
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